Claris Injectables has joined Baxter International (Baxter), a global medical products company.
Claris Injectables’ broad portfolio of products will advance Baxter’s commitment to patient care and access by helping increase the supply of essential medicines to meet the needs of both healthcare professionals and patients. Sterile medication production is a core strength for Baxter, which manufactures a broad range of generic injectable medications—including both frozen and liquid preparations—that treat some of the most pressing healthcare issues facing patients today.
Claris Injectables’ world-class capabilities, technologies and expertise will be combined with Baxter’s differentiated manufacturing and robust presence in the hospital channel. The teams at Claris Injectables and Baxter intend to ensure a seamless transition for business partners, including suppliers, distributors and customers. Claris Injectables’ products will continue to be manufactured and supplied to customers, as usual.
For more information, please see the announcement press release at Baxter.com. Business partners should contact their established Claris Injectables representative.